Concurrently, it has been reported that TIM-3 blockade enhanced IFN-γ expression by CD8+ T-cells in a murine orthotopic mammary carcinoma model and reduced the population of MDSCs in head and neck squamous cell carcinoma (23, 24). This evidence concerns the gene CD8A and breast carcinoma.